openPR Logo
Press release

Chikungunya Fever Market Research Analysis by Manufacturers and Consumption Forecast 2023

12-06-2017 01:42 PM CET | Health & Medicine

Press release from: Market Research Future

/ PR Agency: Market Research Future
Chikungunya Fever Market

Chikungunya Fever Market

The study report Global Chikungunya Fever Market covers the market analysis for the regions - North America, Europe, Asia Pacific/ Southeast Asia and RoW and country analysis of China, Japan, and India focusing on top manufacturers in global market and the market share they hold including their contribution to the market growth
The Chikungunya Fever Market is expected to grow at CAGR 5.86% during forecast period.
Top key players for the chikungunya fever market are Quest Diagnostics Incorporated. (U.S.A), Alere. (U.S.A), Genome Diagnostics Pvt. Ltd. (India), altona Diagnostics (Europe), Bio-Rad Laboratories, Inc. (U.S.A), Sanat Products Ltd. (India), Taj Pharmaceuticals Limited. (India), and Etubics Corporation (U.S.A).
Chikungunya is a mosquito borne viral disease caused by the RNA virus belonging to the alphavirus genus of family Togaviridae. Chikungunya fever has been reported in more than 60 countries of Asia, Africa, Europe and the Americas. Its transmission from human to human is facilitated by the bites of infected female mosquitoes. Most commonly, the mosquitoes involved are Aedes aegypti and Aedes albopictus. Currently, there is no cure for the disease and the treatments are focussed only to relieve the symptoms. In 2016, according to the World Health Organisation, 349 936 suspected and 146 914 laboratory confirmed cases of chikungunya were reported to the PAHO regional office. Countries that reported the most cases were Brazil (265 000 suspected cases), Bolivia and Colombia (19 000 suspected cases, respectively).
Increasing per capita healthcare expenditures, rising R&D investments by the market players, and growing geriatric population are the major factors that will drive the market growth during the forecasted period. Moreover, pouring government investments and favourable policies will fuel the market. However, factors such as lack of awareness and cost of treatment and diagnosis can restrain the market growth during the forecasted period.
Get Sample Copy At https://www.marketresearchfuture.com/sample_request/4694 .
Segmentation
The chikungunya fever market is segmented on the basis of diagnosis, treatment, and end users.
On the basis of diagnosis, the market is segmented into ELISA based assays, serological tests, virological tests, and others. ELISA based assays is future segmented into IgM based ELISA and IgG ELISA.
On the basis of treatment, the market is segmented into allopathy, homeopathy, ayurveda, and others. The allopathy segmented is sub segmented into anti-pyretics, optimal analgesics, and others. The homeopathy segment is sub segmented into pyroginum, rhus-tox, cedron, and others. The ayurveda segment is sub segmented into amrutharista, mahasudarshana churna, dhanvantaram gutika and others.
On the basis of end users, the market is segmented into hospitals and clinics, academic institutes, research laboratories, and others.
Regional Analysis
The Americas dominate the chikungunya fever market owing to a well-developed healthcare sector. Apart from this, changing lifestyle and increasing healthcare expenditure have boosted the growth of the market in the Americas. Additionally, increasing geriatric population, rising awareness among the people and expanding R&D expenses for the treatment of chikungunya is boosting the market growth.
Europe holds the second largest market for chikungunya fever, which is followed by Asia Pacific. Availability of funds for research, rising patient population and government support for research & development will drive the market. On 22 September 2017, according to the European Centre for Disease Prevention and Control there were about 102 autochthonous chikungunya cases in Italy. Such trend for chikungunya fever was seen across the region. This is expected to boost the market growth during the forecasted period.
According to the World Health Organisation, the major outbreaks of chikungunya fever are seen in Asia and the Indian subcontinent. This made Asia Pacific the fastest growing region for the market due to the presence of a huge patient population and presence of huge opportunity in the market. Moreover, continuously developing economies like India and China within the region have increasing healthcare expenditures which fuels the market growth. According to the Indian Brand Equity Foundation, per capita healthcare expenditure was estimated to grow at a CAGR of 5 % during 2008-15 and reach USD 68.6 by 2015.
On the other hand, the Middle East & Africa has the least share in the chikungunya market due to the presence of poor economy especially in the African region. A majority of the market of this region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure.

Get Discount At https://www.marketresearchfuture.com/check-discount/4694 .
TABLE OF CONTENT

Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
…Continued
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand,
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com

MRFR has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Our Research Analysts are eager to share their knowledge and assist you in refining market research parameters, choosing right market studies, and evaluating both the market scope and the research methodologies of varied segments.

We bridge the gap between our clients and their clients by identifying and decoding just the target group, while generating leads with the highest accuracy.

Years of research into diverse fields of work has ingrained within us, a proficiency so distinguished that our industry-specific specialists identify with your business ideas and feel the pulse of your challenges and opportunities. This enables us for providing assistance, through our consulting and strategic consulting services, in informed managerial decision making. In order to stay updated with technology and work process of the industries, WantStats Research and Media often conducts industrial visits for its research analysts. Relevant inputs from various established market participants, help our clients make significant contribution in respective markets are a huge motivation for all of us to endlessly furnish quality. We depend greatly on profound insights into complex realms of our study.

Pune, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Chikungunya Fever Market Research Analysis by Manufacturers and Consumption Forecast 2023 here

News-ID: 848174 • Views:

More Releases from Market Research Future

Virtual Reality in Gaming Market Size Worth USD 17.1 Billion by 2032 | CAGR 4.70%
Virtual Reality in Gaming Market Size Worth USD 17.1 Billion by 2032 | CAGR 4.70 …
The Virtual Reality (VR) in Gaming Market is experiencing steady growth, driven by advancements in VR hardware, immersive gaming experiences, and increasing consumer demand for interactive entertainment. The market was valued at USD 11.31 billion in 2023 and is projected to expand from USD 11.84 billion in 2024 to USD 17.1 billion by 2032, registering a compound annual growth rate (CAGR) of 4.70% during the forecast period (2024-2032). Key Companies in
Future of Ethernet Switch Market: USD 11.2 Billion Size Forecast by 2032
Future of Ethernet Switch Market: USD 11.2 Billion Size Forecast by 2032
The Ethernet Switch Market is experiencing steady growth, driven by the rapid expansion of data centers, rising internet traffic, and the increasing adoption of cloud computing and enterprise networking solutions. The market was valued at USD 6.4 billion in 2023 and is projected to grow from USD 7.11 billion in 2024 to USD 11.2 billion by 2032, registering a compound annual growth rate (CAGR) of 5.50% during the forecast period
Rising Demand for Advanced Testing Solutions Driving Digital Oscilloscope Market to USD 6.12 Billion by 2032
Rising Demand for Advanced Testing Solutions Driving Digital Oscilloscope Market …
The Digital Oscilloscope Market is witnessing robust growth, driven by the rising demand for advanced testing equipment, innovations in signal analysis technologies, and the growing adoption of digital devices across industries. The market was valued at USD 3.67 billion in 2022 and is projected to expand to USD 6.12 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.24% during the forecast period (2024-2032). Key Companies in Digital Oscilloscope
Super Capacitors Market Set for 18.16% CAGR, Reaching USD 2.50 Billion by 2032
Super Capacitors Market Set for 18.16% CAGR, Reaching USD 2.50 Billion by 2032
The Global Super Capacitors Market is witnessing significant growth, driven by rising demand for energy-efficient storage solutions, rapid adoption of electric vehicles (EVs), and advancements in renewable energy systems. The market was valued at USD 0.544 billion in 2023 and is projected to reach USD 2.501 billion by 2032, growing at a compound annual growth rate (CAGR) of 18.16% during the forecast period (2024-2032). Key Companies in Super Capacitors Market include • Maxwell

All 5 Releases


More Releases for Chikungunya

Chikungunya market is expected to reach USD 1.4 billion by 2034
Chikungunya is a mosquito-borne viral disease caused by the chikungunya virus (CHIKV), transmitted primarily by Aedes aegypti and Aedes albopictus. The infection is characterized by sudden high fever, severe joint pain, rash, headache, and fatigue. While rarely fatal, chikungunya often leads to chronic arthritis-like symptoms lasting months to years, creating a significant burden on healthcare systems. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71953 Global spread is accelerating due to
Chikungunya Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportu …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries. What Is the Projected Growth of the Chikungunya Market? In recent times, there has been robust growth in the chikungunya market size. It is projected to expand from $0.59 billion in 2024 to $0.65 billion in 2025, with a compound annual growth rate (CAGR) of 9.8%. Factors that have contributed to this
Chikungunya Pipeline Insight 2025: 10+ Advancing Therapies and Key Companies in …
The therapeutic landscape for Chikungunya, a viral disease transmitted by mosquitoes that causes severe joint pain, fever, and rash, is rapidly evolving, fueled by advancements in antiviral research and vaccine development. Leading biopharmaceutical companies such as Valneva, Moderna Therapeutics, Themis Bioscience, FIT Biotech, Bharat Biotech, and Emergex Vaccines are at the forefront of developing innovative therapies, targeting various stages of the virus lifecycle, immune modulation, and pain management to alleviate
Chikungunya Fever Global Clinical Trials Review, H2, 2018: Researchmoz.us
Researchmoz added Most up-to-date research on "Chikungunya Fever Global Clinical Trials Review, H2, 2018" to its huge collection of research reports. An insight on the important factors and trends influencing the market. Latest clinical trial report, Chikungunya Fever Global Clinical Trials Review, H2, 2018" provides an overview of Chikungunya Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Chikungunya Fever. Report includes an overview
Chikungunya Fever Market Segmentation 2018 with Recent Trend by 2023
Chikungunya Fever Market - Highlights Chikungunya fever is a mosquito borne disease. The caU.S.Ative agent is a RNA virus that belongs to the alphavirus genus of the family Togaviridae. The transmission of the disease occurs from human to human by the bites of infected female mosquitoes. Most commonly, the mosquitoes involved are Aedes aegypti and Aedes albopictus. The symptoms of the disease includes muscle pain, headache, nausea, fatigue and rash. There is
Chikungunya Fever Market Worldwide Segmentation with Top Key Merchant – Avail …
Chikungunya Fever Market - Highlights Chikungunya fever is a mosquito borne disease. The caU.S.Ative agent is a RNA virus that belongs to the alphavirus genus of the family Togaviridae. The transmission of the disease occurs from human to human by the bites of infected female mosquitoes. Most commonly, the mosquitoes involved are Aedes aegypti and Aedes albopictus. The symptoms of the disease includes muscle pain, headache, nausea, fatigue and rash. There is